Jump Financial, LLC Janux Therapeutics, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$35.29 - $50.26 $638,749 - $909,706	-18,100 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$35.12 - $64.78 $84,604 - $156,055	2,409 Added 15.35%	18,100 $758,000
Q1 2024 May 13, 2024	BUY	$7.93 - $49.75 $124,429 - $780,627	15,691 New	15,691 $590,000
Q2 2023 Oct 21, 2024	SELL	$11.08 - $15.92 $80,651 - $115,881	-7,279 Reduced 40.22%	10,821 $128,000
Q2 2023 Aug 07, 2023	BUY	$11.08 - $15.92 $119,896 - $172,270	10,821 New	10,821 $128,000

166

37.6M

85.3K

654K

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $2.34B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.